These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students. Socan M; Berginc N Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668 [TBL] [Abstract][Full Text] [Related]
9. Febrile seizures following measles and varicella vaccines in young children in Australia. Macartney KK; Gidding HF; Trinh L; Wang H; McRae J; Crawford N; Gold M; Kynaston A; Blyth C; Yvonne Z; Elliott E; Booy R; Buttery J; Marshall H; Nissen M; Richmond P; McInytre PB; Wood N; Vaccine; 2015 Mar; 33(11):1412-7. PubMed ID: 25444797 [TBL] [Abstract][Full Text] [Related]
10. Australian childhood immunisation coverage, 1 July to 30 June cohort, assessed as at 30 September 2015. Hendry A; Commun Dis Intell Q Rep; 2016 Mar; 40(1):E177-8. PubMed ID: 27080025 [No Abstract] [Full Text] [Related]
11. Immunity against vaccine-preventable diseases among pregnant employees in Germany. A situation analysis before the introduction of the Measles Protection Act. Wolfschmidt-Fietkau A; Goertz RS; Goertzen S; Schmid K; Seidling M; Gherman E; Ochmann U; Drexler H Vaccine; 2024 Sep; 42(22):125996. PubMed ID: 38824086 [TBL] [Abstract][Full Text] [Related]
12. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M; Broder KR; Temte JL; Snider DE; Seward JF; MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]. Buxbaum S; Doerr HW; Allwinn R Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190 [TBL] [Abstract][Full Text] [Related]
16. Australian Paediatric Surveillance Unit annual report, 2013. Deverell M; Zurynski YA; Elliott EJ; Commun Dis Intell Q Rep; 2014 Dec; 38(4):E343-2. PubMed ID: 25631597 [TBL] [Abstract][Full Text] [Related]
17. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258 [TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737 [TBL] [Abstract][Full Text] [Related]